iRhom2 in AD SIGNED
iRhom2 in neuroinflammation and pathogenesis of Alzheimer’s Disease
Total Cost €
0EC-Contrib. €
0Partnership
0Views
0iRhom2 in AD project word cloud
Explore the words cloud of the iRhom2 in AD project. It provides you a very rough idea of what is the project "iRhom2 in AD" about.
Project "iRhom2 in AD" data sheet
The following table provides information about the project.
| Coordinator |
KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN
Organization address contact info |
| Coordinator Country | Germany [DE] |
| Project website | http://www.sciencedirect.com/science/article/pii/S0945053X16301329 |
| Total cost | 159˙460 € |
| EC max contribution | 159˙460 € (100%) |
| Programme |
1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility) |
| Code Call | H2020-MSCA-IF-2014 |
| Funding Scheme | MSCA-IF-EF-ST |
| Starting year | 2015 |
| Duration (year-month-day) | from 2015-12-01 to 2017-11-30 |
Partnership
Take a look of project's partnership.
| # | ||||
|---|---|---|---|---|
| 1 | KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN | DE (MUENCHEN) | coordinator | 159˙460.00 |
Map
Project objective
Alzheimer’s disease (AD) is the most common form of dementia in the elderly, a syndrome characterized by loss of memory and cognitive decline. AD has a dramatic socio-economical impact that is foreseen to worsen in the near future unless a cure is found. The pathology is triggered by the accumulation of Aβ oligomers that begins a cascade culminating with the formation of neurofibrillary tangles within the neuron and cell death. Neuroinflammation is emerging to play a key role in this process and it has been associated with the progression of the disease. The rhomboid-like protein iRhom2 has been recently identified as a genetic risk factor for AD, even though the underlying mechanism remains to be characterized. iRhom2 recently emerged as a novel pro-inflammatory protein required to traffic TACE (tumor necrosis factor-α converting enzyme) towards the plasma membrane and guide its maturation, thereby regulating the release of TNFα, a cytokine implicated in several inflammatory diseases. Consequently, iRhom2-/- mice are protected from sepsis and rheumatoid arthritis, which involve TNFα-dependent inflammation. In addition, the concept is emerging that iRhom2 may regulate trafficking of additional clients other than TACE, thus controlling other signalling events in neuroinflammation. The main objective of this proposal is to characterize the role of iRhom2 in neuroinflammation and in the progression of AD. I plan to cross an AD mouse model with iRhom2-/- mice and evaluate role of iRhom2 in the progression of the disease. In addition, I will use avant-garde proteomic approaches to identify novel iRhom2 clients in primary macrophages. Candidates relevant in neuroinflammation and AD will be further validated using an array of biochemical and functional assays. From this research I aim to identify new targets to develop therapies for treatment of AD, in line with the objectives of H2020 Work Programme to promote healthy ageing of the EU citizens.
Publications
| year | authors and title | journal | last update |
|---|---|---|---|
| 2016 |
Simone D. Scilabra, Kazuhiro Yamamoto, Martina Pigoni, Kazuma Sakamoto, Stephan A. Müller, Alkmini Papadopoulou, Stefan F. Lichtenthaler, Linda Troeberg, Hideaki Nagase, Kenji Kadomatsu Dissecting the interaction between tissue inhibitor of metalloproteinases-3 (TIMP-3) and low density lipoprotein receptor-related protein-1 (LRP-1): Development of a “TRAP†to increase levels of TIMP-3 in the tissue published pages: , ISSN: 0945-053X, DOI: 10.1016/j.matbio.2016.07.004 |
Matrix Biology | 2019-06-14 |
| 2016 |
Stephan A. Müller, Simone D. Scilabra, Stefan F. Lichtenthaler Proteomic Substrate Identification for Membrane Proteases in the Brain published pages: , ISSN: 1662-5099, DOI: 10.3389/fnmol.2016.00096 |
Frontiers in Molecular Neuroscience 9 | 2019-06-14 |
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "IRHOM2 IN AD" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "IRHOM2 IN AD" are provided by the European Opendata Portal: CORDIS opendata.
